Imiquimod is FDA-approved for the treatment of external anogenital warts, actinic keratoses, and superficial basal cell carcinomas. Imiquimodâ€™s 5% cream formulation resulted in a statistically significant improvement in treatment effectiveness for external anogenital warts compared with a vehicle cream.